Question 1

What is ImmunityBio, Inc.'s total costs & expenses?

Accepted Answer

ImmunityBio, Inc. (IBRX) reported total costs & expenses of $114M in Q1 2026.

Question 2

How has ImmunityBio, Inc.'s total costs & expenses changed year-over-year?

Accepted Answer

ImmunityBio, Inc.'s total costs & expenses increased by 40.8% year-over-year, from $80.95M to $114M.

Question 3

What is the long-term trend for ImmunityBio, Inc.'s total costs & expenses?

Accepted Answer

Over 2 years (2023 to 2025), ImmunityBio, Inc.'s total costs & expenses has grown at a 0.9% compound annual growth rate (CAGR), from $362.87M to $369.32M.

Question 4

What does total costs & expenses mean?

Accepted Answer

Total costs and expenses aggregate all operating and non-operating costs incurred by the company, including research and development, selling, general, and administrative expenses, and cost of revenue. This metric provides a comprehensive view of the company's total cash burn and operational overhead. It is a critical measure for evaluating the company's cost structure and operational discipline.

Line item	Three Months Ended March 31, 2026	Three Months Ended March 31, 2025
Research and development – related parties	3,219	2,258
Selling, general and administrative	44,461	31,977
Selling, general and administrative – related parties	1,309	677
Total operating costs and expenses	113,997	80,946
Loss from operations	(69,791)	(64,429)
Other income (expense), net
Interest and investment income, net	2,314	887
Change in fair value of warrant liabilities	(295,413)	(448)

Total costs & expenses at other companies

Other financials

Income statement

Balance sheet

Cash flow

Valuation

Profitability

Returns & leverage

Where this comes from

FAQ

Ask your AI about ImmunityBio, Inc.'s total costs & expenses.

ImmunityBio, Inc. IBRX Total costs & expenses